Patient Research In Self-Management of Asthma (PRISMA)
The objective of this study was to investigate if a nurse-led telemonitoring programme is effective and cost-effective in asthmatic outpatients, aged seven years and older.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Nurse-Led Telemonitoring Programme in Asthmatic Outpatients: a Randomized Controlled Trial|
- Asthma-specific quality of life at one year.
- Asthma symptoms at one year
- generic quality of life at one year
- direct and indirect costs during one year
- satisfaction with and feasibility of the intervention at one year.
|Study Start Date:||January 2003|
|Estimated Study Completion Date:||November 2004|
At the present day asthma is one of the most common chronic illnesses worldwide and the prevalence is still increasing. Asthma can be treated and controlled with guidance of health care professionals, and self-monitoring is an important aspect in this control.
Respiratory nurses have become common caregivers in the treatment and control of asthma. Advances in information and communication technology have created the potential to monitor the asthma status of patients at a distance, named telemonitoring. These two developments come together in nurse-led telemonitoring programmes. Lung function tests, from which the peak expiratory flow (PEF) is the most commonly used, are recorded into an electronic monitor. By transferring monitor data to a central database a nurse can continuously supervise the disease status of individual patients. The use of stepwise protocols can enable nurses to independently adjust the medication by one step.
Design: Randomized controlled trial comparing a nurse-led telemonitoring programme versus regular care in asthmatic outpatients aged 7 years and older.
Primary outcome parameter: asthma-specific quality of life. Secondary outcome parameters: symptoms, generic quality of life, direct and indirect costs, satisfaction.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00411346
|University Hospital Maastricht|
|Maastricht, Limburg, Netherlands, 6202 AZ|
|Study Chair:||Emiel FM Wouters, MD PhD||Department of Respiratory Medicine|